HealthQuill Pharma
Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved by the US Food and Drug Administration.
Drugs Health Pharma

Israel’s Teva gets FDA nod for treating schizophrenia in adult patients

HQ Team October 10, 2026: Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved.

Read More
The US Food and Drug Administration has approved Asahi Kasei Therapeutics, Inc’s oral drug to treat mucocutaneous lesions caused by herpes simplex virus (HSV) for adults with weakened immune systems.
Drugs Health Pharma

FDA clears Asahi Kasei’s oral drug to treat herpes virus in immunodeficient

The US Food and Drug Administration has approved Asahi Kasei Therapeutics, Inc’s oral drug to treat mucocutaneous lesions caused by herpes simplex virus.

Read More
GSK Plc will invest $800 million in Montgomery, Pennsylvania to build a biopharmaceutical innovation and manufacturing hub, according to the state governor Josh Shapiro.
Drugs Medical Pharma

GSK Plc to invest $800 million in Pennsylvania for biopharma hub

GSK Plc will invest $800 million in Montgomery, Pennsylvania to build a biopharmaceutical innovation and manufacturing hub, according to the state governor Josh.

Read More
China’s Abogen Biosciences has signed a $7.8 billion licensing and option pact with Novartis AG to make messenger RNA-encoded therapies, which have the potential to treat autoimmune diseases in a more advanced form than the existing ones.
Drugs Health Pharma

Novartis inks $7.8b deal with China’s Abogen for mRNA trial therapy

HQ Team October 4, 2026: China’s Abogen Biosciences has signed a $7.8 billion licensing and option pact with Novartis AG to make messenger.

Read More
The European Commission has approved AbbVie Inc.’s drug for the treatment of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs.
Drugs Health Pharma

EC approves AbbVie Inc.s drug for a type of juvenile idiopathic arthritis

HQ Team September 22, 2026: The European Commission has approved AbbVie Inc.’s drug for the treatment of active polyarticular juvenile idiopathic arthritis in.

Read More
American pharmaceutical company Johnson & Johnson’s investigational drug met its main goal during end-stage trials for the treatment of manic episodes in adults with bipolar I disorder, according to the company.
Drugs Pharma Research

J&J’s test drug for manic episodes in bipolar disorder meets main goal

HQ Team September 22, 2026: American pharmaceutical company Johnson & Johnson’s investigational drug met its main goal during end-stage trials for the treatment.

Read More
Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic patients during an end-stage trial, better than rival Eli Lilly’s drug.
Health Pharma Research

Novo Nordisk’s test drug outperforms rival Lilly’s in diabetic patients

HQ Team September 21, 2026: Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic.

Read More
The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to treat people with a type of breast cancer that has worsened after at least one hormone treatment.The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to treat people with a type of breast cancer that has worsened after at least one hormone treatment.
Drugs Health Pharma

FDA clears Eli Lilly’s combination drug for metastatic breast cancer

HQ Team September 21, 2026: The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to.

Read More
Australia's Telix Pharmaceuticals will buy ITM Isotope Technologies Munich SE for an upfront payment of $1.65 billion on a cash- and debt-free basis to pocket the Germany-based company’s therapeutic radioisotopic solutions.
Drugs Health Pharma

Australia’s Telix to buy ITM Isotope Technologies for $1.65 billion

HQ Team September 21, 2026: Australia’s Telix Pharmaceuticals will buy ITM Isotope Technologies Munich SE for an upfront payment of $1.65 billion on.

Read More
The death toll from the Ebola virus, which is sweeping through the heart of the Central African region of the Democratic Republic of the Congo (DRC), has neared 3,500 with about 7,000 confirmed cases, the second-largest Ebola outbreak on record.
Drugs Health Pharma

Death toll in Congo’s worst Ebola virus outbreak set to cross 7,000: CDC says

HQ Team September 14, 2026: The death toll from the Ebola virus, which is sweeping through the heart of the Central African region.

Read More